BRIEF published on 04/16/2026 at 18:05, 8 hours 1 minute ago Oxurion receives a transparency notification from Atlas Special Opportunities II LLC Transparency Digital Assets Participations Investments Oxurion
BRIEF published on 04/16/2026 at 18:05, 8 hours 1 minute ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Shareholding Euronext Brussels Atlas Special Opportunities Oxurion NV
PRESS RELEASE published on 04/16/2026 at 18:00, 8 hours 6 minutes ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding shareholding crossing threshold under Belgian Transparency legislation Transparency Notification Shareholding Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC
BRIEF published on 04/07/2026 at 18:05, 9 days 8 hours ago Oxurion Postpones Annual Shareholders Meeting Financial Calendar Shareholders Meeting Investment Risks Oxurion Pharmaceutical Outsourcing
BRIEF published on 04/07/2026 at 18:05, 9 days 8 hours ago Oxurion postpones its Annual General Meeting Pharmaceutical Digital Assets General Assembly Report Oxurion
PRESS RELEASE published on 04/07/2026 at 18:00, 9 days 8 hours ago Postponement Annual Shareholders Meeting Oxurion NV postpones Annual Shareholders Meeting to June 1st, 2026 due to pending annual accounts. The pharmaceutical outsourcing company specializes in acquiring European subcontractors. Forward-looking statements in press release Forward-looking Statements Postponement Oxurion NV Pharmaceutical Outsourcing European Subcontractors
BRIEF published on 03/19/2026 at 18:35, 28 days 7 hours ago Oxurion Announces Intent to Acquire International CRO Acquisition Clinical Research Pharmaceutical International Expansion Oxurion
BRIEF published on 03/19/2026 at 18:35, 28 days 7 hours ago Oxurion plans to acquire an international CRO Growth Strategy Acquisition Clinical Development Oxurion International CRO
PRESS RELEASE published on 03/19/2026 at 18:30, 28 days 7 hours ago Oxurion signs a letter of intent for the acquisition of an international CRO Oxurion NV (Euronext Brussels: OXUR) announces the signing of a letter of intent for acquiring an international CRO, strengthening its clinical development strategy Acquisition Clinical Development Euronext Brussels CRO Oxurion NV
BRIEF published on 03/18/2026 at 18:05, 29 days 8 hours ago Oxurion receives a transparency notification from Atlas Special Opportunities Pharmaceutical Financial Transparency Atlas Special Opportunities Oxurion Digital Investments
Published on 04/17/2026 at 02:00, 6 minutes ago UraniumX Announces Closing Of Final Tranche Of Non-Brokered Private Placement
Published on 04/16/2026 at 23:32, 2 hours 34 minutes ago Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale
Published on 04/16/2026 at 21:30, 4 hours 36 minutes ago Organto Foods Expands Financing Facilities with Rabobank
Published on 04/16/2026 at 15:20, 10 hours 46 minutes ago Datavault AI Goes Live with First Edge GPU Sites in New York and Philadelphia; $1.44B-$1.92B Quantum-Ready Fleet to Reach 100+ U.S. Cities by End of 2026
Published on 04/16/2026 at 23:40, 2 hours 25 minutes ago Coventry Ranks #1 in 2025 Life Settlement League Table Report
Published on 04/16/2026 at 21:37, 4 hours 28 minutes ago Approval of the Offer Document concerning the voluntary tender offer for shares of NEXT RE SIIQ S.p.A.
Published on 04/16/2026 at 21:00, 5 hours 5 minutes ago Vizrt AI Keyer kills the green screen and creates virtual scenes in any environment
Published on 04/16/2026 at 20:35, 5 hours 30 minutes ago EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 19:17, 6 hours 48 minutes ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 18:02, 8 hours 4 minutes ago Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026
Published on 04/16/2026 at 17:54, 8 hours 11 minutes ago Aéroports de Paris S.A - March 2026 traffic figures
